Thomas Gajewski
directors
bioinformatics and system biology
Aduro Biotech
Netherlands
Biography
Dr. Gajewski is the leader of the Immunology and Cancer program at the University of Chicago Comprehensive Cancer Center, Director of Melanoma Oncology, and a Professor in the Ben May Cancer Institute. His research interests include the role of the STING (Stimulator of Interferon Genes) pathway in immunity, the molecular and cellular regulation of T lymphocyte activation and differentiation, and the application of this information in immune-based cancer therapy. Dr. Gajewski has published more than 200 papers in peer-reviewed journals on basic aspects of T cell biology, anti-tumor immunity, and melanoma therapy. He was formerly President of the Society for Immunotherapy of Cancer, has served as an editor for Cancer Research and the Journal for Immunotherapy of Cancer and has received numerous awards and honors including the Burroughs Wellcome Fund Clinical Scientist Award for Translational Research and the American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy.
Research Interest
Phylogenetics & Evolutionary Biology
